Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 4
2003 4
2004 3
2005 5
2006 5
2007 3
2008 3
2009 1
2010 4
2011 1
2012 7
2013 7
2014 2
2015 3
2016 5
2017 4
2018 6
2019 3
2020 4
2021 2
2022 4
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy of Guillain-Barré syndrome.
Liu S, Dong C, Ubogu EE. Liu S, et al. Among authors: ubogu ee. Hum Vaccin Immunother. 2018;14(11):2568-2579. doi: 10.1080/21645515.2018.1493415. Epub 2018 Jul 12. Hum Vaccin Immunother. 2018. PMID: 29953326 Free PMC article. Review.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group. van Schaik IN, et al. Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Lancet Neurol. 2018. PMID: 29122523 Free article. Clinical Trial.
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team. Nowak RJ, et al. Among authors: ubogu e. Neurology. 2022 Jan 25;98(4):e376-e389. doi: 10.1212/WNL.0000000000013121. Neurology. 2022. PMID: 34857535 Free PMC article.
Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells.
Garrity R, Arora N, Haque MA, Weis D, Trinh RT, Neerukonda SV, Kumari S, Cortez I, Ubogu EE, Mahalingam R, Tavares-Ferreira D, Price TJ, Kavelaars A, Heijnen CJ, Shepherd AJ. Garrity R, et al. Among authors: ubogu ee. Brain Behav Immun. 2023 Aug;112:220-234. doi: 10.1016/j.bbi.2023.06.011. Epub 2023 Jun 12. Brain Behav Immun. 2023. PMID: 37315702 Free PMC article.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG, Singleton JR, Aperghis A, Coffey CS, Creigh P, Cudkowicz M, Conwit R, Ecklund D, Fedler JK, Gudjonsdottir A, Hauer P, Herrmann DN, Kearney M, Kissel J, Klingner E, Quick A, Revere C, Stino A; NeuroNEXT NN108 TopCSPN Study Team. Smith AG, et al. JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711. JAMA Neurol. 2023. PMID: 37870862 Free PMC article. Clinical Trial.
Mirtazapine-induced serotonin syndrome.
Ubogu EE, Katirji B. Ubogu EE, et al. Clin Neuropharmacol. 2003 Mar-Apr;26(2):54-7. doi: 10.1097/00002826-200303000-00002. Clin Neuropharmacol. 2003. PMID: 12671522
The role of chemokines in Guillain-Barré syndrome.
Chiang S, Ubogu EE. Chiang S, et al. Among authors: ubogu ee. Muscle Nerve. 2013 Sep;48(3):320-30. doi: 10.1002/mus.23829. Epub 2013 Jul 27. Muscle Nerve. 2013. PMID: 23447114 Free PMC article. Review.
The Human Blood-Nerve Barrier Transcriptome.
Palladino SP, Helton ES, Jain P, Dong C, Crowley MR, Crossman DK, Ubogu EE. Palladino SP, et al. Among authors: ubogu ee. Sci Rep. 2017 Dec 12;7(1):17477. doi: 10.1038/s41598-017-17475-y. Sci Rep. 2017. PMID: 29234067 Free PMC article.
84 results